Editorial Advisory Board Members

Alan S Louie
Research Director, Health Industry Insights, an IDC Company, USA

Alan Louie is Research Director at Health Industry Insights. He leads HII's pharmaceutical R&D market research efforts, with an emphasis on technology and innovation in clinical development, personalised medicine, and BI. Louie brings to HII more than 24 years of experience from the diagnostics, biotechnology, and consulting industries.

Christopher-Paul Milne
Associate Director, Tufts Center for the Study of Drug Development, Tufts University

Christopher Milne is the Associate Director of The Tufts Center for the Study of Drug Development. Milne received his master's degree in public health from the Johns Hopkins University.

Douglas Meyer
Senior Director, Aptuit Informatics Inc.

Douglas Meyer received a BS in Pharmacy and an MBA from the University of Connecticut and is a member of the Investigation Products Steering Committee of ISPE. A senior director at Aptuit Informatics, he currently leads the Client Services division at Aptuit Informatics with responsibilities for the implementation of software at the customer site as well as training and validation support for clients.

Frank A Jaeger
Director, New Business Development, Solvay Pharmaceuticals, Inc., USA

Frank Jaeger is currently Director of New Business Development in the NeuroScience division at Solvay Pharmaceuticals. Frank has held cross-disciplinary positions previously in Clinical Research, Medical Services, and Marketing.

Georg C Terstappen
Chief Scientific Officer, Siena Biotech S.p.A., Italy

Georg C Terstappen is the Chief Scientific Officer of Siena Biotech. He is also the coordinator of ADIT-which is one of three large European research projects in Alzheimer's disease funded by the EU Framework Programme 6-and an adjunct Professor of Biotechnology. Georg has 16 years of experience in drug discovery and worked at Bayer AG, GlaxoWellcome and GlaxoSmithKline where his last position was Director of Systems Research. He has a diploma in biology obtained from the University of Duesseldorf (Germany) and carried out his thesis work at the Max-Planck-Institute in Cologne (Germany). He received his PhD for work conducted at the Research Centre Juelich (Germany)-a member of the Helmholtz Association-and was a postdoctoral research scientist at the Max-Planck-Institute in Cologne.

Kenneth I Kaitin
Director and Professor of Medicine, Tufts Center for the Study of Drug Development, Tufts University, USA

Kenneth Kaitin is Director of the Tufts Center for the Study of Drug Development, an academic drug policy research group, and Professor of Medicine at Tufts University School of Medicine in Boston, Massachusetts, USA.

Laurence Flint
Associate Director, Clinical Research, Schering-Plough Research Institute

Laurence Flint is a board certified paediatrician and Associate Director of Clinical Research in the Allergy, Immunology, and Respiratory group at Schering-Plough Research Institute. Laurence holds a BS in Biology and English from the University of Scranton, an MS in Biology and an MBA from Fairleigh Dickinson University, and a medical degree from UMDNJ-New Jersey Medical School.

Neil J Campbell
CEO, Mosaigen Inc. and Partner, Endeavour Capital Asia Ltd., USA

Neil J Campbell is currently Chairman and CEO for Mosaigen™, Inc., a global Life Science development corporation, located in Rockville, Maryland and Partner with Endeavour Capital in Asia. During his career, he has successfully developed and introduced over 200 products in healthcare, life sciences and information technology. He earned his MBA and MA in Management Systems from Webster University in Saint Louis, Missouri and his BS-BA from Norwich University in New England.

Phil Kaminsky
Founder, Center for Biopharmaceutical Operations, University of California, Berkeley, USA

Phil Kaminsky is an associate professor in the Industrial Engineering and Operations Research Department, and one of the founders of Center for Biopharmaceutical Operations at the University of California at Berkeley.

Rustom Mody
Director, Quality and Strategic Research, Intas Biopharmaceuticals Limited, India.

Rustom Mody has 11 years of experience in the pharmaceutical industry. He currently heads the Quality Management System and Strategic Research Initiative at Intas Biopharmaceuticals Limited. He has worked in various aspects of project development such as plant design and setup, process and method development, scale-up and has interfaced with various National / International regulatory agencies.

Sanjoy Ray
Director, Technology Innovation, Merck Research Laboratories, USA.

Sanjoy Ray has a PhD in Protein Engineering from Imperial College, London and held a postdoctoral research fellowship in Structural Biophysics at Harvard University. He has 14 years of IT experience, enabling scientific high-performance computing at Boston's Children's Hospital and the Whitehead Institute / MIT. He created and currently leads a new information technology innovation group at Merck & Co., Inc.

Sasikant Misra
Deputy Director, Confederation of Indian Industry, India.